Who owns Applied Therapeutics Inc?
- CUSIP Number: 03828a101
Tip: Access positions for across all investors
Analyze quarterly positions in Applied Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Applied Therapeutics stock
Who bought or sold Applied Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management | 22M | $2.2M | 2% | Dec 2025 |
|
| Vanguard Group | 6.4M | $635k | 25% | Dec 2025 |
|
| Renaissance Technologies | 2.7M | $271k | 100% | Dec 2025 |
|
| Adage Capital Partners GP | 1.2M | $121k | -45% | Dec 2025 |
|
| State Street Corporation | 558k | $56k | 8% | Dec 2025 |
|
| Virtu Financial | 496k | $50k | 873% | Dec 2025 |
|
| Marshall Wace | 337k | $34k | -87% | Dec 2025 |
|
| Northern Trust | 245k | $25k | 41% | Dec 2025 |
|
| Gts Securities | 200k | $20k | 100% | Dec 2025 |
|
| Susquehanna International | 53k | $5.3k | -92% | Dec 2025 |
|
| Diadema Partners | 20k | $2.0k | 6% | Dec 2025 |
|
| Tower Research Capital | 20k | $2.0k | -43% | Dec 2025 |
|
| FMR | 184.00 | $17.995200 | -99% | Dec 2025 |
|
| Barclays | 1.00 | $0 | -100% | Dec 2025 |
|
Who sold out of Applied Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Knoll Capital Management | Dec 2025 | 6.1M | $605k |
| Deltec Asset Management | Dec 2025 | 3.8M | $385k |
| BlackRock | Dec 2025 | 3.3M | $318k |
| Pathstone Holdings | Dec 2025 | 2.6M | $305k |
| Jane Street | Dec 2025 | 2.1M | $209k |
| Geode Capital Management | Dec 2025 | 1.5M | $149k |
| Qube Research & Technologies | Sep 2025 | 1.2M | $706k |
| Millennium Management | Dec 2025 | 1.1M | $105k |
| UBS Group | Dec 2025 | 719k | $72k |
| Deutsche Bank Aktiengesellschaft | Dec 2025 | 622k | $62k |
| Graham Capital Management | Dec 2025 | 573k | $57k |
| Equitec Proprietary Markets | Dec 2025 | 553k | $55k |
| Lynx1 Capital Management | Dec 2025 | 411k | $41k |
| Hennion & Walsh Asset Management | Dec 2025 | 327k | $33k |
| Bank of New York Mellon | Dec 2025 | 254k | $25k |
| Rockefeller Capital Management | Dec 2025 | 242k | $24k |
| Royal Bank of Canada | Sep 2025 | 203k | $0 |
| Citadel Advisors | Dec 2025 | 193k | $19k |
| Morgan Stanley | Dec 2025 | 179k | $18k |
| Change Path | Dec 2025 | 170k | $17k |
| Goldman Sachs Group | Dec 2025 | 146k | $15k |
| Roble, Belko & Company | Dec 2025 | 66k | $7.0k |
| Tudor Investment Corporation | Dec 2025 | 58k | $5.7k |
| Sphera Funds Management | Dec 2025 | 50k | $5.0k |
| Group One Trading | Dec 2025 | 49k | $4.9k |
| SG Americas Securities | Dec 2025 | 42k | $4.0k |
| Adams Wealth Management | Dec 2025 | 39k | $3.9k |
| CacheTech | Dec 2025 | 39k | $3.9k |
| XTX Topco | Sep 2025 | 24k | $14k |
| Cresset Asset Management | Dec 2025 | 17k | $1.7k |
| Point72 Asset Management | Dec 2025 | 17k | $1.7k |
| AQR Capital Management | Dec 2025 | 13k | $1.3k |
| Perennial Investment Advisors | Dec 2025 | 12k | $1.2k |
| Jpmorgan Chase & Co | Sep 2025 | 7.6k | $4.6k |
| Quest Partners | Dec 2025 | 4.7k | $466.100000 |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 3.0k | $297.102600 |
| SBI Securities | Dec 2025 | 788.00 | $79.036400 |
| Rhumbline Advisers | Dec 2025 | 544.00 | $54.019200 |
| Optiver Holding B.V. | Dec 2025 | 427.00 | $42.998900 |
| CWM | Sep 2025 | 376.00 | $0 |
| Federation des caisses Desjardins du Quebec | Dec 2025 | 84.00 | $7.996800 |